H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Census population 675,647. Massachusetts Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Boston clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Boston storefront.
Your Regenerative Medicine Clinic Partner in Boston, MA for clinics & physicians. Partner with Hawk Medica… Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Boston is JK (National Government Services (NGS)) and that adult diabetes here is 8.6% (PLACES 2023), it is selling units, not a program. That is the regenerative medicine clinic conversation we actually have.
National Your Regenerative Medicine Clinic Partner notes (how the product actually works)Massachusetts shares JK with CT, ME, NH, NY, RI, VT. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Boston trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 8.6% of adults — 3.4 points below the U.S. 12% figure. Obesity is 23.4%; arthritis is 17.8%. That is place-level BRFSS modeling, not a clinic census and not a Boston trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Massachusetts.
No. National Government Services (NGS) writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
Point-of-care spin, kit handling, and documentation basics. Injection technique, privileging, and ultrasound guidance remain the clinic’s clinical education path in Massachusetts.
Bring specialty, monthly joint / regenerative volume, and whether you bill JK FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 8.6% diabetes and 17.8% arthritis for Boston — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Boston, MA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Boston is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Boston — 3.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Massachusetts Part B wound biologics follow this contractor (siblings: CT, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Boston. Useful for joint-program math; still needs a diagnosis and privileging.
No Boston storefront. Joe Bradley is an active practice owner. regenerative medicine clinic stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.